{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Coffee & Community: Cutaneous Lymphoma Conversations","title":"Setting a New Standard: Pediatric Guidelines for Mycosis Fungoides  ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/f921a590\"></iframe>","width":"100%","height":180,"duration":1326,"description":"summary\nIn this episode of Coffee and Community, the Cutaneous Lymphoma Foundation discusses the newly developed guidelines for pediatric cutaneous lymphoma with Professor Chalid Assaf. The conversation covers the importance of these guidelines, the unique presentation of cutaneous lymphoma in children, the development process of the guidelines, treatment strategies including the watch and wait approach, and the significance of ongoing research. The episode emphasizes the need for reassurance for parents and highlights the collaborative efforts in treating this rare disease.\nTo review and learn more about the guidelines please visit our website at Pediatric Guidelines for Mycosis Fungoides | Cutaneous Lymphoma Foundation\ntakeaways\nGuidelines are essential for doctors treating cutaneous lymphoma.\nChildren present differently than adults with cutaneous lymphoma.\nThe development of guidelines took about three and a half to four years.\nWatch and wait is a strategy integrated into treatment guidelines.\nPhototherapy is the first-line treatment for early-stage mycosis in children.\nOngoing research is crucial for understanding pediatric cutaneous lymphoma.\nParents should be reassured about treatment possibilities and outcomes.\nCollaboration among experts is vital in rare disease treatment.\nThe guidelines represent a significant step forward in pediatric care.\nChapters\n\n00:00 Introduction to Cutaneous Lymphoma Guidelines\n02:27 Understanding Pediatric Cutaneous Lymphoma\n04:56 The Process of Developing Guidelines\n07:24 Watch and Wait: A Careful Approach\n09:50 Treatment Options for Pediatric Patients\n12:27 Long-term Management and Prognosis\n14:55 Future Research and Global Awareness\n17:35 Final Thoughts and Community Support","thumbnail_url":"https://img.transistorcdn.com/ohJty2uz38ziShPo3VY6ikeHhLW3XwRh7e3pa76JHs4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lN2Q5/Zjg0OWNjNDZiODY0/YzUyNDA4ODg3ZjQw/ZDZkMy5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}